Comment on Ajjan et al. Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice
Diabetes Care · 01.12.2026 · 49 (12) · e228-e229
DOI: 10.2337/dc26-1733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 20.11.2026. Verfasst von Klavs Würgler Hansen. Die Arbeit nennt 5 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hansen, K. W. (2026). Comment on Ajjan et al. Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice. Diabetes Care, 49(12), e228-e229. https://doi.org/10.2337/dc26-1733
Vancouver
Hansen KW. Comment on Ajjan et al. Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice. Diabetes Care. 2026;49(12):e228-e229. doi:10.2337/dc26-1733
BibTeX
@article{Hansen2026,
author = {Hansen, Klavs Würgler},
title = {Comment on Ajjan et al. Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {12},
pages = {e228--e229},
doi = {10.2337/dc26-1733}
}
EUVIMED